Conservative Treatment of PAS With or Without IIL (PASIIL)
Primary Purpose
Placenta Accreta, Cesarean Hysterectomy, Pelvic Devascularization
Status
Recruiting
Phase
Not Applicable
Locations
Egypt
Study Type
Interventional
Intervention
Ligation of the bilateral internal iliac arteries
Shehat's technique
Sponsored by
About this trial
This is an interventional treatment trial for Placenta Accreta
Eligibility Criteria
Inclusion Criteria:
- Age under 35 years old.
- Prenatally diagnosed placenta accreta .
- Planned caesarean section ≤ 37 wks .
- ≤ previous 3 ceserian sections .
- Placenta accretta spectrum grade 1 , 2 ,3 .
- Patients who want to preserve their fertility.
- Patients who refuse hysterectomy .
Exclusion Criteria:
- Cases with high risk of intraoperative blood loss as hemorrhagic disorders and thrombocytopenia .
- Cases on anticoagulant therapy.
- Patients who completed her family.
- Hemodynamicaly unstable patients.
- Finally cases who refused to get enrolled in the study.
Sites / Locations
- Ayman DawoodRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Study group
Control group
Arm Description
Conservative management of PAS with Ligation of the bilateral internal iliac arteries
Conservative treatment with Shehata's technique and no internal iliac ligation
Outcomes
Primary Outcome Measures
Intraoperative blood loss
the volume of blood collected in the suction apparatus, excluding the volume of liquor collected, this will be done by meticulous recording of the blood volume in the suction apparatus before opening the uterus and then calculating the exactly added amount of liquor, so that it becomes excluded from the calculation) to the calculated volume of blood obtained from the pre and postoperative difference in weight of the towels and drapes placed beneath the patients, using the following formula: (WET Item Gram Weight - DRY Item Gram Weight¼milliliters of blood within the item) .
Cesarean hysterectomy rate
The success of procedure in prevention of hysterectomy
Secondary Outcome Measures
Operative time
From skin to skin duration in minutes
Operative and postoperative complications
Any operative organ injury
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT05232981
Brief Title
Conservative Treatment of PAS With or Without IIL
Acronym
PASIIL
Official Title
Conservative Management of Placenta Accreta Spectrum With or Without Internal Iliac Ligation: A Randomized Controlled Trial
Study Type
Interventional
2. Study Status
Record Verification Date
July 2023
Overall Recruitment Status
Recruiting
Study Start Date
May 1, 2022 (Actual)
Primary Completion Date
January 1, 2024 (Anticipated)
Study Completion Date
January 1, 2024 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Tanta University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
In the current study, the investigators aimed to compare the benefits of internal iliac ligation in placenta accreta spectrum
Detailed Description
This randomized control trial will be conducted at Tanta University hospital, Egypt, from 2022 to 2024. Tanta University Hospital is considered the main tertiary hospital at the center of Nile Delta .
Cases, suspected to have PAS, are recruited from the outpatient clinic, and subsequently transferred for ultrasonod gray scale and dopplar for assessment of placental location, invasion and commont on the fetus .
Cases are diagnosed to have PAS by the following criteria Placenta lacunae , Loss of clear zone , Bladder wall interruption, uterovesical hypervascularity and increased vascularity in inferior part of lower uterine segment extending into parametrial region9 will be included in the study. MRI will be done if ultrasonod isn't conclusive , cases with posterior placenta, depth of placental invasion, relationship to posterior bladder wall and presence of parametrial invasion .
All cases will be subjected to the following:
A written consent will be obtained from the patients after informing them about the risk of intrapartum and postpartum hemorrhage, the need for blood transfusion, and the possibility of hysterectomy if needed to stop massive blood loss. The consent is approved by the medical ethical committee of Tanta University Hospital.
Full history taking with special attention on:
Age of the patient .
Obstetric History especially number of children and sex .
Detailed history of previous deliveries and gynecological procedures.
History of any previous surgery.
Full general and abdominal examination including weight, height, body mass index (BMI) and blood pressure.
Routine lab investigation : CBC, coagulation profile ( PT , PTT , Bleeding time , Clotting time ) , ABO , RH Typing , virology .
Randamisation and Allocation :
Patients will be given aclosed envelope containing either letter C or letter I . The envelope that opened by patient will not change allocation .
The enrolled cases will be allocated into two groups with 1:1 allocation. Group 1 :( Study group ) include cases that will undergo bilateral internal iliac arteries ligation .
Group II :( Control group ) will undergo conservative management by three step technique (Shehata's technique) .
Intervention
Preoperative preparation :
Planned elective CS ≤ 37 wk unless the clinical situations necessitate earlier termination of pregnancy.
A multidisciplinary team including a two senior obstetricians, vascular surgeon , a urologist, an anesthesiologist, and a pediatrician are involved in the operation.
Four units of cross-matched blood are prepared for each patient .Ureteric catheters will be prepared to be used when indicated . Drugs that control bleeding will be preparedsuch as Oxytocin, Carbetocin, Ergometrine, Misoprostol and Tranexamic acid.
All cases undergo general anesthesia by a specialized team. The operation started with Pfannenstiel skin incision and careful dissection of urinary bladder till exposing the uterus.
Uterine incision above placental edge will be done to avoid transplacental incision that triggers heavy bleeding and then extraction of the baby with ecbolic administration, the uterus with the placenta inside will be exteriorized outside the abdomen .Redissecion of U.B will be done if previous dissection at the beginning of the surgery is insuffient.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Placenta Accreta, Cesarean Hysterectomy, Pelvic Devascularization
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Masking Description
Patients only will be masked
Allocation
Randomized
Enrollment
90 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Study group
Arm Type
Experimental
Arm Description
Conservative management of PAS with Ligation of the bilateral internal iliac arteries
Arm Title
Control group
Arm Type
Active Comparator
Arm Description
Conservative treatment with Shehata's technique and no internal iliac ligation
Intervention Type
Procedure
Intervention Name(s)
Ligation of the bilateral internal iliac arteries
Intervention Description
opening the posterior peritoneum overlying the bifurcation of the common iliac arteries. Then careful dissection of the internal iliac artery is carried out on each side and the anterior division of the internal iliac artery is ligated 4 cm below the bifurcation of the common iliac on both sides by single ligation procedure using Vicryl 1.0 .
Re-checking of the femoral pulsation of both sides is performed. Then, the placenta is removed manually in a piecemeal manner, any remaining bleeding points from the placental site are then controlled by hemostatic sutures .
Intervention Type
Procedure
Intervention Name(s)
Shehat's technique
Intervention Description
The three-step technique (Shehata's technique) entailed 3 steps, the first step is double bilateral ligation of uterine arteries before placental separation. Uterine artery ligation is made at 2 levels. First will be done at the isthmus and second will be done 1 cm above the cesarean incision. Regarding timing of ligation , we will apply the uterine artery ligation before placental separation to minimize blood loss at the attempt of placental separation.
Placenta is separated manually either totally or in piecemeal. If manual separation failed, placenta is removed by scissors.
Application of quadruple sutures is done at the lower uterine segment to compress and secure the neovascularization in the bed of placenta.
Insertion of triple way catheter is commenced from inside the uterine incision downwards using long artery forceps or uterine sound and the pulled by the assistant from below. The catheter balloon is inflated by 50 cc saline and left for 48 hours
Primary Outcome Measure Information:
Title
Intraoperative blood loss
Description
the volume of blood collected in the suction apparatus, excluding the volume of liquor collected, this will be done by meticulous recording of the blood volume in the suction apparatus before opening the uterus and then calculating the exactly added amount of liquor, so that it becomes excluded from the calculation) to the calculated volume of blood obtained from the pre and postoperative difference in weight of the towels and drapes placed beneath the patients, using the following formula: (WET Item Gram Weight - DRY Item Gram Weight¼milliliters of blood within the item) .
Time Frame
6 months
Title
Cesarean hysterectomy rate
Description
The success of procedure in prevention of hysterectomy
Time Frame
6 months
Secondary Outcome Measure Information:
Title
Operative time
Description
From skin to skin duration in minutes
Time Frame
intraoperative
Title
Operative and postoperative complications
Description
Any operative organ injury
Time Frame
6 months
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
20 Years
Maximum Age & Unit of Time
35 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Age under 35 years old.
Prenatally diagnosed placenta accreta .
Planned caesarean section ≤ 37 wks .
≤ previous 3 ceserian sections .
Placenta accretta spectrum grade 1 , 2 ,3 .
Patients who want to preserve their fertility.
Patients who refuse hysterectomy .
Exclusion Criteria:
Cases with high risk of intraoperative blood loss as hemorrhagic disorders and thrombocytopenia .
Cases on anticoagulant therapy.
Patients who completed her family.
Hemodynamicaly unstable patients.
Finally cases who refused to get enrolled in the study.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Ayman Dawood, MD
Phone
+201020972067
Email
ayman.dawood@med.tanta.edu.eg
Facility Information:
Facility Name
Ayman Dawood
City
Tanta
Country
Egypt
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Nahla Elbeheiry, Msc
Phone
+201115983165
Email
nahla.elbeheiry@med.tanta.edu.eg
First Name & Middle Initial & Last Name & Degree
Nahla Elbeheiry, Msc
12. IPD Sharing Statement
Plan to Share IPD
Yes
IPD Sharing Plan Description
On valuable request
IPD Sharing Time Frame
6 months
IPD Sharing Access Criteria
full acess
Learn more about this trial
Conservative Treatment of PAS With or Without IIL
We'll reach out to this number within 24 hrs